The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
Conclusion
The 2023 ACR/EULAR CPPD disease classification criteria have excellent performance characteristics and will facilitate research in this field.
Source: Annals of the Rheumatic Diseases - Category: Rheumatology Authors: Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., Fuller, A., Rosenthal, A., Becce, F., Bardin, T., Ea, H.-K., Filippou, G., Fitzgerald, J., Iagnocco, A., Liote, F., McCarthy, G. M., Ramonda, R., Richette, P., Sivera, F., A Tags: ARD, EULAR papers Criteria Source Type: research
More News: Arthritis | Calcium | Calcium Pyrophosphate Dihydrate Deposition (CPPD) | Laboratory Medicine | Pain | Rheumatology